Home » Upcoming Events » Cardiovascular, metabolic and kidney disease: crosscutting science and best practice

Cardiovascular, metabolic and kidney disease: crosscutting science and best practice

When and where

1 July 2019
Royal College of Physicians of London
11 St Andrews Place, Regent's Park, London, NW1 4LE

Past event

Cardiovascular, metabolic and kidney disease: crosscutting science and best practice

NEW: Attending from a research charity or not-for-profit organisation? We've set up a special rate to make booking simple - make sure you book your place today! 

Multimorbidity and clustering of common diseases are major problems for health service providers. This 1-day conference aims to stimulate discussion and ideas and help set the foundation for establishing strategic partnerships to ultimately improve the health of patients with multimorbidity.

What you will learn

  • Learn how advances in digital health, biomarkers and omics, imaging and telemedicine can be used to deliver personalised medicine.
  • Hear from industry experts on the development of multisystem cardiovascular pathological processes such as inflammation and fibrosis.
  • Discover how current data and biosample resources can further the future of integrated research.
  • Analyse the epidemiology of multimorbidity in vascular disease specialties, and determine the related health needs of the UK population.

Dr Matthew Graham-Brown is NIHR academic clinical lecturer in renal medicine, University of Leicester. Read up on why he thinks our Cardiovascular conference on 1 July is so important for clinicians and scientists alike: 

'Dealing with the increasing complexity and inter-related nature of co-morbid illnesses that affect patients are some of the greatest challenges in modern medicine. Diseases across organ systems often co-exist due to clustering of shared risk-factors and the processes that drive disease progression, such as systemic inflammation or fibrosis, are common to many organ systems. Despite this we still tend to view organ dysfunction in isolation, dealing only with 'our bit'. I am delighted that the Renal Association, Kidney Research UK, the NIHR and the RCP have developed the multi-morbidity conference on July 1st to help clinicians and scientists better understand the nature of multi-morbidity, how we might take a more wholistic view of patient care and develop our practices to better serve our patients.'

Who should attend?

  • physicians, allied healthcare professionals, and scientists in nephrology, cardiology, diabetes, elderly care, mental health, metabolic, endocrine and stroke medicine
  • health economists
  • specialists in 'omics' research
  • pharmaceutical, diagnostic and imaging companies
  • patients - acting in an advisory capacity.

If you are in LTFT we offer discounts on a case-by-case basis, please contact conferences@rcplondon.ac.uk for further information.

Sponsorship & Exhibition

For sponsorship and exhibition opportunities please email darryl.deprez@rcplondon.co.uk.


Please see our GDPR statement below.

RCP membership

RCP members benefit from discounted delegate rates at conferences, training and events. Become a member today and join our community of 36,000 physicians around the world.

Thank you

We'd like to thank our principal partner for the event, AstraZeneca.


We'd like to thank our industry sponsor for the event, Pharmacosmos.


Please see the presentations from the day below. If you cannot find a presentation, the RCP has not been given permission to distribute these materials.

Claire Corps 443.3 KB
David Wheeler 2.47 MB
Dorothea Nitsch 1.69 MB
Fergus Caskey 1.1 MB
Jackie Taylor 2.47 MB
John McMurray 4.11 MB
John Wilding 3.39 MB
Maarten Taal 2.44 MB
Martin Cowie 2.81 MB
Paul Elliott 3.65 MB
Robert Unwin 3.89 MB
Sue Francis 5.2 MB

Conference executive summary and briefing report.

Executive Summary 339.88 KB
Briefing Report 598.84 KB